Skip to main content
Clinical Trials/EUCTR2009-011382-80-GB
EUCTR2009-011382-80-GBActive, not recruitingPhase 1

Intravenous Iron: biomarkers and treatment strategies in anaemic Colorectal cancer patients. - Intravenous Iron: measuring response in anaemic surgical patients

ottingham University Hospital0 sites20 target enrollmentStarted: May 8, 2009Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Sponsor
Enrollment
20

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Inclusion Criteria

  • Age >18yrs
  • Diagnosis of Colorectal Cancer and a defined surgical operation date
  • Biochemically detectable anaemia.
  • Women of child bearing potential (who have a negative pregnancy
  • test) must agree to use methods of medically acceptable forms of contraception during the study; (e.g. intra-uterine device (IUD) or a double-barrier method of oral contraception with condom)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • Patients with a recognised allergy to intravenous iron, or related products.
  • A concurrent medical condition(s) that,in the view of the investigator, would prevent compliance or participation or jeopardize the health of the patients.
  • Any of the following groups:
  • Children; those unable to consent for themselves; pregnant females; prisoners

Investigators

Sponsor
ottingham University Hospital

Similar Trials